ReviewIndian journal of pediatrics2025
Neonatal Invasive Candidiasis: Current Concepts.
Review in Indian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Short tandem repeat genotyping of Pichia kudriavzevii isolates reveals long-standing clinical clade with high transmission potential.Medical mycology · 2026Article
- Diagnostic Failure in Invasive Fungal Infections: Causes, Clinical Consequences, and Mitigation Strategies.Journal of fungi (Basel, Switzerland) · 2026Review
- Genomic insights into a clade-specificmBio · 2026Article
- Neonatal Candidemia in Latin America: Trends, Resistance, and Prevention Strategies (2008-2025).Journal of fungi (Basel, Switzerland) · 2026Review
- Irrational and Inappropriate Use of Antifungals in the NICU: A Narrative Review.Antibiotics (Basel, Switzerland) · 2026Review
- Outbreak of mucocutaneousAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- Addressing the silent threat: managing invasiveFrontiers in pediatrics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Neonatal invasive candidiasis (NIC) is an important cause of morbidity and mortality, especially in preterm and very low birthweight infants, with the incidence being inversely correlated with gestational age and birth weight. Epidemiological studies in high-income countries show Candida albicans and Candida parapsilosis being the commonest species causing NIC, while in low- and middle-income countries NIC is more often caused by non-albicans Candida species with higher rates of antifungal resistance. The increased incidence of fluconazole-resistant C. parapsilosis and multi-drug-resistant Candida auris causing NIC is of concern and challenges our management approaches. Identification of the causative Candida sp. and susceptibility testing needs to be optimised to guide targeted treatment. Infection prevention and control measures are crucial to prevent neonatal Candida colonisation and the development of NIC. In this concise review, authors will discuss the global changing epidemiology of NIC, the increase of antifungal resistant Candida species and outbreaks, current management approaches, and the value of infection prevention and control measures in the prevention of NIC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.